Table 3 Patient treatments and outcomes, children (n = 24) and adult patients
From: Chronic non-bacterial osteomyelitis: a comparative study between children and adults
Variable | Pediatric patients | Adult patients |
|---|---|---|
Treatment | ||
Antibiotic treatment, n (%) | 15 (62.5%) | 5/9 (56%) |
- Duration, weeks, mean (range) | 4 (0–25) | 5.1 (0–26) |
NSAID, n (%) | 20 (83.3%) | 10 (100%) |
- NSAID continuously, n (%) | 18 (75%) | 2 (20%) |
Steroids, n (%) | 8 (33.3%) | 3 (30%) |
- systemic, n (%) | 7 (29.2%) | 2 (20%) |
DMARDS, n (%) | 2 (8.3%) | 3 (30%) |
- Sulfasalazine, n | 1 | 1 |
- Methotrexate, n | 1 | 3 |
- Leflunomide, n | 0 | 1 |
- Cyclosporine A, n | 0 | 1 |
Anti-TNF, n (%) | 5 (20.8%) | 1 (10%) |
Bisphosphonates, n (%) | 13 (54.1%) | 1 (10%) |
Final outcome | ||
Remission, n (%) | 15 (62.5%) | 3 (30%) |
Complications, n (%) | 8 (33.3%) | 6 (60%) |
Fracture | 2 (8.3%) | 3 (30%) |